Alnylam Pharmaceuticals, Inc.
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2009 | $2.40 |
| FY2010 | $2.36 |
| FY2016 | $0.55 |
| FY2017 | $0.90 |
| FY2018 | $0.74 |
| FY2019 | $2.01 |
| FY2020 | $4.29 |
| FY2021 | $7.13 |
| FY2022 | $8.53 |
| FY2023 | $14.64 |
| FY2024 | $17.61 |
| FY2025 | $27.58 |
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2009 | $2.40 |
| FY2010 | $2.36 |
| FY2016 | $0.55 |
| FY2017 | $0.90 |
| FY2018 | $0.74 |
| FY2019 | $2.01 |
| FY2020 | $4.29 |
| FY2021 | $7.13 |
| FY2022 | $8.53 |
| FY2023 | $14.64 |
| FY2024 | $17.61 |
| FY2025 | $27.58 |